Chronic Kidney Disease News

Acetazolamide was associated with an acute, reversible drop in GFR without impacting glucose metabolism for adults with type 1 diabetes and preserved kidney function, according to study data.

Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.

There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.

Akebia Therapeutics and U.S. Renal Care have entered a multiyear commercial supply contract to offer the anemia drug Vafseo to patients on dialysis, according to a press release.

Older veterans with advanced chronic kidney disease can benefit from discussions about their care goals conducted over telehealth with health care providers, according to researchers.

When counseling women with kidney disease about pregnancy, nephrologists and women’s health providers must emphasize intentionality.

Follow-up albuminuria testing can be an important step in kidney care following initial abnormal results from a urine protein dipstick test, according to an analysis of health records.

Long-term albuminuria risks for U.S. adults with Asian/Pacific Islander ancestry who have diabetes and normal kidney function differ across ethnic subgroups, according to data published in Kidney Medicine.

Urea reduction ratio — a metric of hemodialysis efficacy in removing urea — may predict skeletal muscle mass for adults on maintenance hemodialysis, according to research published in the Journal of Renal Nutrition.

Decreases in body weight and HbA1c induced by GLP-1 receptor agonists and other diabetes drugs can reduce the risk for cardiometabolic complications for adults newly diagnosed with type 2 diabetes, researchers reported.